https://www.selleckchem.com/pr....oducts/crenolanib-cp
05). The changes of COX-2 positive expression were associated with the survival time and survival rate (p0.05) in patients with NPC following treatment. T stage, COX-2 expression before treatment and changes in COX-2 expression after treatment were independent factors affecting NPC prognosis (p0.05). Changes in COX-2 expression levels before and after treatment may be a useful indicator for assessing the prognosis of NPC after chemoradiotherapy. Changes in COX-2 expression levels before and after treatment may be a